These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 3896157)

  • 21. [Phase-1 study of the tolerance for increasing doses of recombinant human alpha 2 interferon in patients with advanced cancer].
    Bretaudeau B; Palangie T; Giralt E; Jouve M; Pouillart P; Falcoff E; Fridman WH; Magdelenat H; Derstepani L; Laurent T
    Bull Cancer; 1984; 71(1):40-9. PubMed ID: 6713113
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of interferon-alpha on macrophage activation in patients with ovarian carcinoma and cervical dysplasia.
    Fuith LC; Fuchs D; Hausen A; Hetzel H; Reibnegger G; Werner ER; Wachter H
    J Clin Lab Immunol; 1989 Jun; 29(2):65-9. PubMed ID: 2632803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A cooperative phase I-II study of HLBI in patients with malignant tumors].
    Kimura K
    Gan To Kagaku Ryoho; 1984 Jun; 11(6):1324-31. PubMed ID: 6329104
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Phase II study of 4'-O-tetrahydropyranyl-adriamycin (THP-ADM) in patients with gynecological cancer].
    Kato T; Nishimura H; Umezu J; Takeuchi S; Kanazawa K; Inoue H; Suzuki M; Hirono M; Suzuki T; Okajima H
    Gan To Kagaku Ryoho; 1985 Oct; 12(10):1962-7. PubMed ID: 4051511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical effect of human lymphoblastoid interferon in patients with multiple myeloma].
    Yoshida M; Ohta M; Muroi K; Takeda K; Kitagawa S; Tsuboyama A; Sakamoto S; Miura Y; Mutoh Y
    Gan To Kagaku Ryoho; 1984 Jul; 11(7):1394-8. PubMed ID: 6742866
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-alpha therapy of renal cancer.
    Neidhart JA; Gagen MM; Young D; Tuttle R; Melink TJ; Ziccarrelli A; Kisner D
    Cancer Res; 1984 Sep; 44(9):4140-3. PubMed ID: 6378379
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A multiple-dose phase I trial of recombinant leukocyte A interferon in cancer patients.
    Sherwin SA; Knost JA; Fein S; Abrams PG; Foon KA; Ochs JJ; Schoenberger C; Maluish AE; Oldham RK
    JAMA; 1982 Nov; 248(19):2461-6. PubMed ID: 6752447
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phase II trial of alpha-lymphoblastoid interferon given weekly as treatment of advanced breast cancer.
    Sarna GP; Figlin RA
    Cancer Treat Rep; 1985 May; 69(5):547-9. PubMed ID: 4005877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phase I study of weekly high-dose human lymphoblastoid interferon.
    Connors JM; Silver HK
    Cancer Treat Rep; 1984 Sep; 68(9):1093-6. PubMed ID: 6478449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phase I study of Wellferon (human lymphoblastoid alpha-interferon) as cancer therapy: clinical results.
    Sarna G; Figlin R; McCarthy S
    J Biol Response Mod; 1983; 2(2):187-95. PubMed ID: 6644335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gynecologic cancers: factors affecting survival after pulmonary metastasectomy.
    Clavero JM; Deschamps C; Cassivi SD; Allen MS; Nichols FC; Barrette BA; Larson DR; Pairolero PC
    Ann Thorac Surg; 2006 Jun; 81(6):2004-7. PubMed ID: 16731120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Leukocyte interferon (IFN alpha) in patients with epithelial ovarian carcinoma.
    Freedman RS; Gutterman JU; Wharton JT; Rutledge FN
    J Biol Response Mod; 1983; 2(2):133-8. PubMed ID: 6644331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Phase II study of recombinant alpha interferon in the treatment of advanced non-small cell lung carcinoma.
    Grunberg SM; Kempf RA; Itri LM; Venturi CL; Boswell WD; Mitchell MS
    Cancer Treat Rep; 1985 Sep; 69(9):1031-2. PubMed ID: 4028036
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical experience with alpha and beta interferon in childhood cancer].
    Ise T; Ohira M; Takayama J; Hanada M; Muchi H; Fukuma H; Beppu Y; Nomura K
    Gan To Kagaku Ryoho; 1984 Sep; 11(9):1855-62. PubMed ID: 6591860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A phase I study of Adp53 (INGN 201; ADVEXIN) for patients with platinum- and paclitaxel-resistant epithelial ovarian cancer.
    Wolf JK; Bodurka DC; Gano JB; Deavers M; Ramondetta L; Ramirez PT; Levenback C; Gershenson DM
    Gynecol Oncol; 2004 Aug; 94(2):442-8. PubMed ID: 15297186
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Introduction of natural interferon-alpha "Sumiferon"].
    Tsukagoshi S
    Gan To Kagaku Ryoho; 1987 Sep; 14(9):2800-3. PubMed ID: 3631977
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Interferons--its method of administration and adverse effect related to pharmacokinetics ].
    Furue H
    Gan To Kagaku Ryoho; 1984 Feb; 11(2):186-93. PubMed ID: 6582804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Bropirimine (U-54461S) early phase II clinical studies--to investigate the efficacy and safety of bropirimine treatment on various malignant tumors (urological, hematologic, and dermal cancers)].
    Furue H; Machida T; Masaoka T; Ikeda S
    Gan To Kagaku Ryoho; 1997 Jan; 24(1):67-75. PubMed ID: 9020948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Profile of ovarian cancer patients seeking information from a web-based decision support program.
    Markman M; Markman MR; Belland A; Petersen J
    J Womens Health (Larchmt); 2006 Apr; 15(3):312-8. PubMed ID: 16620190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.